Amcasertib (BBI503)

Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.

Price Not Available 5mg Amcasertib (BBI503) Supplier Page

Trivial name	N/A
Catalog Number	S8572
Molecular Formula	C31H33N5O2S
CAS#	1129403-56-0
Inchi	InChI=1S/C31H33N5O2S/c1-5-36(6-2)15-14-32-30(38)28-19(3)26(33-20(28)4)17-24-23-16-22(12-13-25(23)34-29(24)37)27-18-39-31(35-27)21-10-8-7-9-11-21/h7-13,16-18,33H,5-6,14-15H2,1-4H3,(H,32,38)(H,34,37)/b2 4-17+
Inchi Key	QDWKGEFGLQMDAM-JJIBRWJFSA-N
SMILES	CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)C4=CSC(=N4)C5=CC=CC=C5)NC2=O)C
Size	5mg
Supplier Page	http://www.selleckchem.com/products/amcasertib-bbi503.html
Additional Information	https://file.selleck.cn/downloads/struct/Amcasertib-BBI503-chemical-structure-S8572.gif